REV: Responsibly and reliably powering industry
With a focus on the creation of innovative technology and forward-thinking practical solutions, REV offers flexible, durable, reliable
Joseph Papa
Valeant Pharmaceuticals Announces Expanded Discounts For Nitropress And Isuprel
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) (“Valeant” or the “Company”) has announced that, pursuant to a recommendation by its Patient Access and Pricing Committee, the company will make